Hippocampal-derived extracellular vesicle synergistically deliver active adenosine hippocampus targeting to promote cognitive recovery after stroke

Ling-Kun Zhang,Li Liu,Qingpeng Liu,Yiquan Zhang,Ziqing Li,Haoming Xu,Weiwei Bai,Yiyan Guo,Dandan Zhang,Zhendong Chen,Kunwen Xia,Chu-Hua Li,Jian Ge,Yan-Qing Guan
DOI: https://doi.org/10.1016/j.colsurfb.2024.113746
IF: 5.999
2024-01-07
Colloids and Surfaces B Biointerfaces
Abstract:Ischemic stroke is a neurological disease that leads to brain damage and severe cognitive impairment. In this study, extracellular vesicle(Ev) derived from mouse hippocampal cells (HT22) were used as carriers, and adenosine (Ad) was encapsulated as Ev-Ad to target the damaged hippocampus. The results showed that Ev-Ad had significant antioxidant effect and inhibited apoptosis. In vivo, Ev-Ad reduced cell death and reversed inflammation in hippocampus of ischemic mice, and improved long-term memory and learning impairment by regulating the expression of the A1 receptor and the A2A receptor in the CA1 region. Thus, the developmental approach based on natural carriers that encapsulating Ad not only successfully restored nerves after ischemic stroke but also improved cognitive impairment in the later stage of ischemic stroke convalescence. The development and design of therapeutic drugs provides a new concept and method for the treatment of cognitive impairment in the convalescent phase after ischemic stroke.
materials science, biomaterials,biophysics,chemistry, physical
What problem does this paper attempt to address?